A pediatrician is completing a well-child examination for a 4-year-old girl who will soon begin preschool. The patient was diagnosed with systemic juvenile idiopathic arthritis one year ago and is currently maintained on weekly methotrexate and a high-dose daily regimen of oral prednisone. Her growth parameters track along the 50th percentile, and her physical examination reveals no active joint inflammation or deformities. A review of her electronic immunization registry confirms she received all standard childhood vaccines appropriately up to her 18-month visit. According to current guidelines for clinical preventive services, which of the following is the most appropriate management plan for this patient today?
- Perform visual acuity screening, administer the DTaP and IPV vaccines, and withhold the MMR and varicella vaccinesAnswer
- BPerform visual acuity screening and administer the DTaP, IPV, MMR, and varicella vaccines
- CPerform the M-CHAT-R autism screening questionnaire, administer the DTaP and IPV vaccines, and withhold the MMR and varicella vaccines
- DPerform the M-CHAT-R autism screening questionnaire and administer the DTaP, IPV, MMR, and varicella vaccines
- EObtain a capillary blood lead level, administer the DTaP and IPV vaccines, and schedule administration of the MMR and varicella vaccines for the following month
Answer
The most appropriate management plan is to perform visual acuity screening, administer the DTaP and IPV vaccines, and withhold the MMR and varicella vaccines.
The correct management combines the appropriate age-based screening (visual acuity) with the safe administration of inactivated vaccines (DTaP, IPV). The USPSTF strongly recommends vision screening at least once for children aged 3 to 5 years to detect amblyopia or its risk factors. Furthermore, while 4-year-old children are routinely due for DTaP, IPV, MMR, and varicella boosters, this patient is severely immunocompromised due to treatment with methotrexate and high-dose prednisone. Therefore, live-attenuated vaccines (MMR and varicella) are strictly contraindicated and must be withheld.
Step-by-Step Solution
Key Concept
Visual acuity screening is recommended for children aged 3 to 5 years. Live-attenuated vaccines (e.g., MMR, varicella) are strictly contraindicated in patients receiving significant immunosuppressive therapy (e.g., high-dose corticosteroids, methotrexate).
Estimated Time:1m 30s